Arkolith/Insider Trading/SLRX/Form 4

Lieber Jonathan I

DirectorSalarius Pharmaceuticals, Inc. (SLRX) · full profile →Form 4 · filed Jun 8, 2022
Net Buying
Open-Market Buys
$7K
Open-Market Sells
$0
Net Open-Market Flow
$7K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 7, 2022Buy(P)38K$0.19$7K38K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001615219-22-000099) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML